Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Early hair loss may indicate risk of insulin resistance.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.